4 ms·
I think the ruling is correct, but someone needs to be doing this research. Dosage research and clinical trials for non-patentable compounds needs to get funde
by jcampbell1 15y ago
I think the ruling is correct, but someone needs to be doing this research. Dosage research and clinical trials for non-patentable compounds needs to get funded. I hope the federal government fixes this hole.
For instance, the FDA had to use a bullshit process to get clinical research done on colchicine for gout. There is also some research that vitamin D deficiency is causing many unnecessary deaths, but no ongoing clinical trials. The status quo needs to get fixed.
- mv 15y agoBullshit process? URL Pharma exploited a loop hole to do 'research' and a clinical trial on a drug that has been known for centuries to work (yes centuries, the plant it is based from has been used since roman times).... Doctors are angry because suddenly the poor patients without insurance could no longer afford medication they need. That research was worthless, proved what was already proven, and exploited a loophole in the FDA grandfathering process to make a company a risk free profit. The price went from $0.09/pill to $4.85/pill overnight. Oh, and an easy citation is wikipedia: http://en.wikipedia.org/wiki/Colchicine http://en.wikipedia.org/wiki/Colchicine http://en.wikipedia.org/wiki/Colchicine#Marketing_exclusivity_in_the_United_States http://en.wikipedia.org/wiki/Colchicine#Marketing_exclusivit...
- jcampbell1 15y agoURL Pharma didn't exploit a thing. The FDA setup the program, and asked drug companies to do the trials. It was the FDA's "Bullshit Process" that caused the problem, not the drug company that did what they were asked. From the article: "That year, the FDA started their "Unapproved Drugs Initiative", through which they sought more rigorous testing of efficacy and safety of colchicine and other unapproved drugs on the market.[26] In exchange for paying for the costly testing, the FDA gave URL Pharma three years of market exclusivity for its Colcrys brand,[27] under the Hatch-Waxman Act"
- felipemnoa 15y ago>>but someone needs to be doing this research It will get done the same way a lot of research that has no immediate monetary value (but still is quite valuable to humanity) gets done. i.e. Astronomy, Anthropology, theoretical physics, etc, etc Big pharma is just trying to scare you.
- deleted 15y ago[deleted]